COURTNEY MAXWELL: Open Payments
NPI 1861155194 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 70 payments from 18 companies in 2025. Trend: 2023 $1,089 · 2024 $2,047 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $352 |
| Janssen Biotech, Inc. | 9 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $168 |
| Madrigal Pharmaceuticals | 3 | $95 |
| Aimmune Therapeutics, Inc. | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| PFIZER INC. | 2 | $43 |
| RedHill Biopharma Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Celltrion USA Inc. | 2 | $36 |
Products named: RINVOQ, TREMFYA, XIFAXAN, DUPIXENT, REZDIFFRA, ZENPEP, VELSIPITY, Talicia.
Industry payments across TN — which companies pay providers there.
